| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/19/2011 | CN101948462A Azaspiroalkene and azaspiroalkane compounds with nicotinic cholinergic receptor activity |
| 01/19/2011 | CN101948439A Extraction method and application to medicine of active alkaloid compounds in cervus nippon temminck |
| 01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
| 01/19/2011 | CN101948416A Compound used for treating metabolic disorder |
| 01/19/2011 | CN101948412A Site-15 deacetylation and site-13 straight-chain sulfamic acid substituted hypocrellin derivative, preparation method and application thereof |
| 01/19/2011 | CN101947319A Medicinal composition for treating and preventing discomfort of people with myocardial ischemia |
| 01/19/2011 | CN101947303A Drug for radical treatment of hypertension and preparation method thereof |
| 01/19/2011 | CN101947301A Medicine composition for preventing and treating vital myocarditis and preparation method thereof |
| 01/19/2011 | CN101947299A Medicinal composition for treating coronary heart disease |
| 01/19/2011 | CN101947287A Oral traditional Chinese medicine for treating haemorrhoids |
| 01/19/2011 | CN101947265A Application of Aleppo avens or compound preparations containing Aleppo avens in preparing drugs for treating cardiovascular and cerebrovascular system diseases |
| 01/19/2011 | CN101947260A Method for controlling quality of capsules for treating haemorrhoids |
| 01/19/2011 | CN101947254A Method for extraction of total salvianolic acid from salvia miltrorrhiza ethanol-precipitation precipitates |
| 01/19/2011 | CN101947251A Method for preparing chickpea isoflavone microcapsules |
| 01/19/2011 | CN101947249A Method for ultrasonic extraction of total saponins of rhizoma panacis majoris |
| 01/19/2011 | CN101947248A Apocynum venetum pulsatile tablet |
| 01/19/2011 | CN101947247A Method for preparing ginkgodipyidamolum injection |
| 01/19/2011 | CN101947244A Disinfection pill |
| 01/19/2011 | CN101947242A Preparation method of deproteinized calf blood extract |
| 01/19/2011 | CN101947235A Medicamentous application of CPE (Conjugated Polyelectrolyte) |
| 01/19/2011 | CN101947232A Use of cactus pear fruit polysaccharides in preparation of medicaments or health-care products |
| 01/19/2011 | CN101947227A Application of compound (I) in preparing medicament for improving atherosclerosis |
| 01/19/2011 | CN101947222A Ointment for treating high blood pressure and preparation method thereof |
| 01/19/2011 | CN101947221A New application of imatinib mesylate |
| 01/19/2011 | CN101947219A Compound telmisartan amlodipine besylate medicinal composition and preparation method thereof |
| 01/19/2011 | CN101947210A Levoamlodipine besylate liposome tablet |
| 01/19/2011 | CN101947199A Nifedipine mucilage and preparation method thereof |
| 01/19/2011 | CN101946985A Element fabric health-improving protective clothing capable of killing and repelling mosquitoes |
| 01/19/2011 | CN101647858B Preparation method of water-soluble extract of red sage root |
| 01/19/2011 | CN101579346B Medicine composition containing amlodipine and ketanserin, and medicine box set and application thereof |
| 01/19/2011 | CN101560213B Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application |
| 01/19/2011 | CN101554432B Fumigating and washing medicine for curing hemorrhoids |
| 01/19/2011 | CN101554412B Traditional Chinese medicine for treating atrial fibrillation |
| 01/19/2011 | CN101507707B Fasudil hydrochloride lipo-microballoons carrier preparation and preparation method thereof |
| 01/19/2011 | CN101485651B Dihydrochalcone derivates and use thereof |
| 01/19/2011 | CN101407811B Dairy-derived antihypertensive 7 peptide tandem gene |
| 01/19/2011 | CN101406495B Medicament for mainly curing cardiovascular disease |
| 01/19/2011 | CN101375849B Novel dosage form of sinomenine medicament or hydrochlorate thereof and preparation technique thereof |
| 01/19/2011 | CN101362731B Heterocyclic compounds and methods of use |
| 01/19/2011 | CN101347476B Health products capable of reducing blood pressure and preparation thereof |
| 01/19/2011 | CN101297897B Chinese medicine preparation for treating cardiovascular and cerebrovascular disease |
| 01/19/2011 | CN101297825B Compound formulation of ginkgo leaf extract |
| 01/19/2011 | CN101292973B Use of chicoric acid in preparing medicaments for treating coronary disease |
| 01/19/2011 | CN101292685B Health care edible oil |
| 01/19/2011 | CN101244207B Traditional Chinese medicament for treating cardiovascular and cerebrovascular diseases with tongue bottom blood-letting acupuncture drug administration |
| 01/19/2011 | CN101244124B Method of preparing mulberry leaf active site and application |
| 01/19/2011 | CN101237885B Agent for regeneration and/or protection of nerves |
| 01/19/2011 | CN101160290B 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 01/19/2011 | CN101103967B Medicine composition containing bevantolol hydrochloride |
| 01/19/2011 | CN101088505B Nanometer breviscapine polymer particle preparation and its preparation process |
| 01/19/2011 | CN101014578B Triazole derivative or salt thereof |
| 01/18/2011 | US7872142 Coumarin derivatives useful as TNFα inhibitors |
| 01/18/2011 | US7872133 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 01/18/2011 | US7872129 Nitrogen compounds such as (6-(3-Methylaminopropyl)-2-(2-tri-fluoromethylphenyl)pyrimidin-4-yl)-(1H -pyrazolo(3,4-b)pyridin-3-yl)-amine, use as glycogen synthase kinase-3 (GSK-3) antagonists |
| 01/18/2011 | US7872127 2-(4-(1-methyl-4-piperidinoxy)benzylamino)-2-methyl-propanamide; nervous system disorders; analgesics; anticonvulsants; sodium channel moderators; antidepressants, antiarrhythmics and for the treatment or prevention of diabetic neuropathy |
| 01/18/2011 | US7872125 1-Methyl,3-((1,3-dichloro-phenyl)-carbonylamino-(1-carboxy- eth-1,2-ylene)-(1,4-phenylene)-)quinazolin-2,4-dione; inhibiting the adhesion of VCAM-1 (vascular cellular adhesion molecules-1) to alpha-4 integrin; antiinflammatory agents; cardiovascular disorders; multiple sclerosis; antiarthritic agent |
| 01/18/2011 | US7872112 comprising rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A),deoxyhypusine synthase (DHS) nucleic acids and polypeptides; human cytomegalovirus immediate-early promoter/enhancer |
| 01/18/2011 | US7872094 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD) |
| 01/18/2011 | US7872035 Angiotensin II antagonists |
| 01/18/2011 | US7872034 Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals |
| 01/18/2011 | US7872001 Gamma d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 01/18/2011 | US7871984 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis |
| 01/18/2011 | US7871644 Mixture of drug, aminoacrylate polymer and acid |
| 01/18/2011 | US7871608 Reversibly inactivated acidified plasmin |
| 01/18/2011 | CA2557395C Benzopyran compound |
| 01/18/2011 | CA2500225C Pyrazole compounds |
| 01/18/2011 | CA2462374C Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage |
| 01/18/2011 | CA2458797C Preparation and diabetic use of gibeberellins |
| 01/18/2011 | CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 01/18/2011 | CA2432077C Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
| 01/18/2011 | CA2416874C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/18/2011 | CA2372850C Synergistic combination comprising roflumilast and a pde-3 inhibitor |
| 01/18/2011 | CA2331460C Heterocyclic inhibitors of p38 |
| 01/13/2011 | WO2011006144A1 Methods of treating and preventing neurological disorders using docosahexaenoic acid |
| 01/13/2011 | WO2011006072A2 Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia |
| 01/13/2011 | WO2011005939A2 Long acting atrial natriuretic peptide (la-anp) and methods for use thereof |
| 01/13/2011 | WO2011005674A1 Dual-acting pyrazole antihypertensive agents |
| 01/13/2011 | WO2011004734A1 Carboxymethylarginine production inhibitor and collagen denaturation inhibitor |
| 01/13/2011 | WO2011004733A1 Activity enhancer for oxidized protein hydrolase |
| 01/13/2011 | WO2011004620A1 Cytoprotective agent |
| 01/13/2011 | WO2011004392A1 Crystalline form of prasugrel hydrobromide, preparation and application thereof |
| 01/13/2011 | WO2011004038A1 Use of l-carnitine for preventing inflammatory cardiac damage associated with arterial hypertension |
| 01/13/2011 | WO2011003365A1 Histone deacetylase inhibitors with branched structure synthesized through click chemistry |
| 01/13/2011 | WO2011003223A1 Pharmaceutical composition for treating or preventing angina or myocardial infarction induced by myocardial ischemia |
| 01/13/2011 | WO2010128346A3 Rosuvastatin manganse, copper, iron and zinc salts with high photochemical stability |
| 01/13/2011 | WO2010116328A3 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines as adp receptor antagonists |
| 01/13/2011 | WO2010102216A3 Enhancing coagulation or reducing fibrinolysis |
| 01/13/2011 | WO2010077101A4 Novel thiazolidinedione derivative and use thereof |
| 01/13/2011 | US20110009631 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/13/2011 | US20110009625 Novel compounds |
| 01/13/2011 | US20110009463 Geranylgeranyl transferase inhibitors and methods of making and using the same |
| 01/13/2011 | US20110009452 Hydroxyalkanyl amides as modulators of chemokine receptor activity |
| 01/13/2011 | US20110009448 Compound |
| 01/13/2011 | US20110009447 Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis |
| 01/13/2011 | US20110009439 Indene derivatives as pharmaceutical agents |
| 01/13/2011 | US20110009434 Crystals of isopropyl ester of n-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl -1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2h)-yl]-l- phenylalanine hydrochloride, production method thereof and use thereof |
| 01/13/2011 | US20110009432 Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof |
| 01/13/2011 | US20110009431 Compositions and methods for treating fibroproliferative disorders |
| 01/13/2011 | US20110009427 Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof |
| 01/13/2011 | US20110009426 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin ii receptor antagonists |